These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16140438)

  • 1. Identification of protective and non-protective T cell epitopes in influenza.
    Crowe SR; Miller SC; Woodland DL
    Vaccine; 2006 Jan; 24(4):452-6. PubMed ID: 16140438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.
    Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z
    Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal lipopeptide primes lung-resident memory CD8+ T cells for long-term pulmonary protection against influenza.
    Deliyannis G; Kedzierska K; Lau YF; Zeng W; Turner SJ; Jackson DC; Brown LE
    Eur J Immunol; 2006 Mar; 36(3):770-8. PubMed ID: 16435281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against lethal influenza virus encephalitis by intranasally primed CD8+ memory T cells.
    Stevenson PG; Hawke S; Bangham CR
    J Immunol; 1996 Oct; 157(7):3065-73. PubMed ID: 8816416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of preexisting immunity to influenza on responses to influenza vectors in mice.
    Langley WA; Bradley KC; Li ZN; Talekar GR; Galloway SE; Steinhauer DA
    Vaccine; 2010 Aug; 28(38):6305-13. PubMed ID: 20656032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination with an acidic polymerase epitope of influenza virus elicits a potent antiviral T cell response but delayed clearance of an influenza virus challenge.
    Crowe SR; Miller SC; Shenyo RM; Woodland DL
    J Immunol; 2005 Jan; 174(2):696-701. PubMed ID: 15634888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic multi-epitope peptides identified in silico induce protective immunity against multiple influenza serotypes.
    Stoloff GA; Caparros-Wanderley W
    Eur J Immunol; 2007 Sep; 37(9):2441-9. PubMed ID: 17668898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precursor frequency and competition dictate the HLA-A2-restricted CD8+ T cell responses to influenza A infection and vaccination in HLA-A2.1 transgenic mice.
    Tan AC; La Gruta NL; Zeng W; Jackson DC
    J Immunol; 2011 Aug; 187(4):1895-902. PubMed ID: 21765016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient vagina-to-lower respiratory tract immune trafficking in a murine model of influenza A virus infection.
    Garulli B; Meola M; Stillitano MG; Kawaoka Y; Castrucci MR
    Virology; 2007 May; 361(2):274-82. PubMed ID: 17222437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.
    Luo M; Tao P; Li J; Zhou S; Guo D; Pan Z
    J Virol Methods; 2008 Dec; 154(1-2):121-7. PubMed ID: 18789973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusing subunit antigens to interleukin-2 and encapsulating them in liposomes improves their antigenicity but not their protective efficacy.
    Wales JR; Baird MA; Davies NM; Buchan GS
    Vaccine; 2005 Mar; 23(17-18):2339-41. PubMed ID: 15755624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uneven distribution of MHC class II epitopes within the influenza virus.
    Crowe SR; Miller SC; Brown DM; Adams PS; Dutton RW; Harmsen AG; Lund FE; Randall TD; Swain SL; Woodland DL
    Vaccine; 2006 Jan; 24(4):457-67. PubMed ID: 16140434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal immunity induced by adenovirus-based H5N1 HPAI vaccine confers protection against a lethal H5N2 avian influenza virus challenge.
    Park KS; Lee J; Ahn SS; Byun YH; Seong BL; Baek YH; Song MS; Choi YK; Na YJ; Hwang I; Sung YC; Lee CG
    Virology; 2009 Dec; 395(2):182-9. PubMed ID: 19836045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies and CD4(+) T-cells mediate cross-protection against H5N1 influenza virus infection in mice after vaccination with a low pathogenic H5N2 strain.
    Droebner K; Haasbach E; Fuchs C; Weinzierl AO; Stevanovic S; Büttner M; Planz O
    Vaccine; 2008 Dec; 26(52):6965-74. PubMed ID: 18848593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
    Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity.
    Okamoto S; Yoshii H; Akagi T; Akashi M; Ishikawa T; Okuno Y; Takahashi M; Yamanishi K; Mori Y
    Vaccine; 2007 Nov; 25(49):8270-8. PubMed ID: 17977633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric virus-like particles for the delivery of an inserted conserved influenza A-specific CTL epitope.
    Cheong WS; Reiseger J; Turner SJ; Boyd R; Netter HJ
    Antiviral Res; 2009 Feb; 81(2):113-22. PubMed ID: 19007818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide-based synthetic recombinant vaccines with anti-viral efficacy.
    Arnon R; Tarrab-Hazdai R; Ben-Yedidia T
    Biologicals; 2001; 29(3-4):237-42. PubMed ID: 11851322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques.
    Itoh Y; Ozaki H; Tsuchiya H; Okamoto K; Torii R; Sakoda Y; Kawaoka Y; Ogasawara K; Kida H
    Vaccine; 2008 Jan; 26(4):562-72. PubMed ID: 18164788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination.
    Zinckgraf JW; Sposato M; Zielinski V; Powell D; Treanor JJ; von Hofe E
    Vaccine; 2009 Aug; 27(39):5393-401. PubMed ID: 19596415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.